DKK1 and prostate carcinoma: Treatment with the humanized immunoglobulin G4 (IgG4) anti-DKK1 antibody, DKN-01, inhibited tumor growth in a natural killer (NK) cell-dependent manner in both a metastatic breast cancer model [10] and a prostate cancer model [11].